Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers [Phase 2]
Phase II study evaluating florbetaben PET imaging to detect or exclude cerebral beta-amyloid in patients with probable Alzheimer's disease; …
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Hormone and Information Processing Study [Phase 3]
Phase 3 clinical trial investigating a hormone- and information-processing–focused intervention for mild cognitive impairment and Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers [Phase 4]
This update reports the completion of a Phase 4 randomized trial comparing donepezil 10 mg daily to placebo in Alzheimer's disease, assessin…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease [Phase 2]
Phase 2 safety study of TRx0237 in Alzheimer's disease patients already taking other Alzheimer's medications was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients [NA]
This clinical trial update notes the completion of a study evaluating a group therapy psychological intervention for caregivers of patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Experimental Study to Validate the "Therapeutic Game" CONEM-BETA [NA]
Clinical trial update indicating completion of an experimental study validating the 'Therapeutic Game' CONEM-BETA for Alzheimer's disease an…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Alzheimer and Sleep [Phase 1]
A Phase 1 clinical trial investigating sleep in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: AZD3293 Thorough QT Study in Healthy Male Volunteers [Phase 1]
Phase 1 thorough QT study of lanabecestat (AZD3293) in healthy male volunteers to assess cardiac repolarization safety; the study sponsored …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Delta-THC in Dementia [Phase 2]
A Phase 2 trial evaluating delta-THC for behavioral disturbances and pain in dementia patients has completed. The study included Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects [Phase 1]
A Phase I dose-escalation study evaluated the safety, tolerability, and pharmacokinetics of a transdermal donepezil patch in healthy male vo…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Citalopram for Agitation in Alzheimer's Disease [Phase 3]
The CitAD Phase 3 trial evaluating citalopram for agitation in Alzheimer's disease has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients [Phase 1]
Phase 1 trial evaluating florbetaben PET imaging to detect amyloid in individuals with mild cognitive impairment or Alzheimer's disease; res…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
This completed clinical trial compares long-term use of galantamine versus unspecified memory-enhancing drugs in patients with Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Progression Delaying Effect of Escitalopram in Alzheimer's Disease [NA]
A completed clinical trial investigated whether escitalopram could delay progression in Alzheimer's disease; results were posted in 2014.
-
CLINICAL_TRIALS research · 2014-06-04Clinical Trial Update: Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls [Phase 1]
Phase 1 clinical trial update involving Parkinson disease, Alzheimer disease, and healthy controls; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating the safety, tolerability, and blood levels of PF-03654746 in Alzheimer's disease was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial update from Florida Atlantic University examined delaying driving impairment in people with mild Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trials of SNUBH-NM-333(18F) for Alzheimer's disease have been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
An observational study evaluating the safety and effectiveness of Galantamine in patients with Alzheimer's disease over 18 months.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Cilostazol Augmentation Study in Dementia [Phase 4]
Phase 4 clinical trial results for cilostazol augmentation in Alzheimer's disease have been posted.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics [NA]
This is a completed clinical trial investigating the effects of sleep deprivation on cerebrospinal fluid amyloid-beta dynamics in Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluating the safety and amyloid imaging effects of subcutaneous bapineuzumab in mild-to-moderate Alzheimer's disease has c…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease [Phase 2]
Phase 2 study evaluating 123-I Iodobenzovesamicol (IBVM) with SPECT imaging in healthy subjects and patients with Alzheimer's disease and Pa…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 study of Octagam 10% intravenous immunoglobulin for mild-to-moderate Alzheimer's disease has completed, with results posted in 2014.…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 safety and cognitive function trial of EVP-6124 (encenicline) in mild-to-moderate Alzheimer's disease has completed.